160 related articles for article (PubMed ID: 9531031)
1. Factor V Leiden and fatal pulmonary embolism.
Vandenbroucke JP; Bertina RM; Holmes ZR; Spaargaren C; van Krieken JH; Manten B; Reitsma PH
Thromb Haemost; 1998 Mar; 79(3):511-6. PubMed ID: 9531031
[TBL] [Abstract][Full Text] [Related]
2. Risk factor profiles in patients with different clinical manifestations of venous thromboembolism: a focus on the factor V Leiden mutation.
Manten B; Westendorp RG; Koster T; Reitsma PH; Rosendaal FR
Thromb Haemost; 1996 Oct; 76(4):510-3. PubMed ID: 8902987
[TBL] [Abstract][Full Text] [Related]
3. The risk of recurrent venous thromboembolism in patients with an Arg506-->Gln mutation in the gene for factor V (factor V Leiden).
Simioni P; Prandoni P; Lensing AW; Scudeller A; Sardella C; Prins MH; Villalta S; Dazzi F; Girolami A
N Engl J Med; 1997 Feb; 336(6):399-403. PubMed ID: 9010145
[TBL] [Abstract][Full Text] [Related]
4. Low prevalence of factor V:Q506 in 41 patients with isolated pulmonary embolism.
Martinelli I; Cattaneo M; Panzeri D; Mannucci PM
Thromb Haemost; 1997 Mar; 77(3):440-3. PubMed ID: 9065990
[TBL] [Abstract][Full Text] [Related]
5. Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke, and venous thrombosis in apparently healthy men.
Ridker PM; Hennekens CH; Lindpaintner K; Stampfer MJ; Eisenberg PR; Miletich JP
N Engl J Med; 1995 Apr; 332(14):912-7. PubMed ID: 7877648
[TBL] [Abstract][Full Text] [Related]
6. Combined effect of factor V Leiden and prothrombin 20210A on the risk of venous thromboembolism--pooled analysis of 8 case-control studies including 2310 cases and 3204 controls. Study Group for Pooled-Analysis in Venous Thromboembolism.
Emmerich J; Rosendaal FR; Cattaneo M; Margaglione M; De Stefano V; Cumming T; Arruda V; Hillarp A; Reny JL
Thromb Haemost; 2001 Sep; 86(3):809-16. PubMed ID: 11583312
[TBL] [Abstract][Full Text] [Related]
7. Risk of venous thrombosis in carriers of the prothrombin G20210A variant and factor V Leiden and their interaction with oral contraceptives.
Aznar J; Vayá A; Estellés A; Mira Y; Seguí R; Villa P; Ferrando F; Falcó C; Corella D; España F
Haematologica; 2000 Dec; 85(12):1271-6. PubMed ID: 11114134
[TBL] [Abstract][Full Text] [Related]
8. Factor V Leiden is associated with higher risk of deep venous thrombosis of large blood vessels.
Arsov T; Miladinova D; Spiroski M
Croat Med J; 2006 Jun; 47(3):433-9. PubMed ID: 16758522
[TBL] [Abstract][Full Text] [Related]
9. Factor V Leiden mutation in relation to fecundity and miscarriage in women with venous thrombosis.
van Dunné FM; Doggen CJ; Heemskerk M; Rosendaal FR; Helmerhorst FM
Hum Reprod; 2005 Mar; 20(3):802-6. PubMed ID: 15618258
[TBL] [Abstract][Full Text] [Related]
10. Factor V leiden homozygosity, dyspnea, and reduced pulmonary function.
Juul K; Tybjaerg-Hansen A; Mortensen J; Lange P; Vestbo J; Nordestgaard BG
Arch Intern Med; 2005 Sep; 165(17):2032-6. PubMed ID: 16186475
[TBL] [Abstract][Full Text] [Related]
11. Factor V Leiden, prothrombin gene mutation, and thrombosis risk in patients with antiphospholipid antibodies.
Chopra N; Koren S; Greer WL; Fortin PR; Rauch J; Fortin I; Senécal JL; Docherty P; Hanly JG
J Rheumatol; 2002 Aug; 29(8):1683-8. PubMed ID: 12180730
[TBL] [Abstract][Full Text] [Related]
12. [Prevalence of Factor V Leiden and the G20210A mutation of the prothrombin gene in a random group of patients with thrombotic episodes].
Alvarez A; Barroso A; Robledo M; Arranz E; Outeiriño J; Benítez J
Sangre (Barc); 1999 Feb; 44(1):7-12. PubMed ID: 10323090
[TBL] [Abstract][Full Text] [Related]
13. Minor events and the risk of deep venous thrombosis.
Eekhoff EM; Rosendaal FR; Vandenbroucke JP
Thromb Haemost; 2000 Mar; 83(3):408-11. PubMed ID: 10744145
[TBL] [Abstract][Full Text] [Related]
14. The risk of mortality and the factor V Leiden mutation in a population-based cohort.
Heijmans BT; Westendorp RG; Knook DL; Kluft C; Slagboom PE
Thromb Haemost; 1998 Oct; 80(4):607-9. PubMed ID: 9798979
[TBL] [Abstract][Full Text] [Related]
15. Risk of recurrent venous thrombosis in patients with G20210A mutation in the prothrombin gene or factor V Leiden mutation.
González-Porras JR; García-Sanz R; Alberca I; López ML; Balanzategui A; Gutierrez O; Lozano F; San Miguel J
Blood Coagul Fibrinolysis; 2006 Jan; 17(1):23-8. PubMed ID: 16607075
[TBL] [Abstract][Full Text] [Related]
16. Factor V Leiden mutation in postthrombotic and non-postthrombotic venous ulcers.
Hafner J; Kühne A; Schär B; Bombeli T; Hauser M; Lüthi R; Hänseler E
Arch Dermatol; 2001 May; 137(5):599-603. PubMed ID: 11346337
[TBL] [Abstract][Full Text] [Related]
17. The role of plasminogen activator inhibitor-1 polymorphism, factor-V-Leiden, and prothrombin-20210 mutations in pulmonary thromboembolism.
Oguzulgen IK; Yilmaz E; Demirtas S; Erkekol FO; Ekim N; Demir N; Numanoglu N; Ozel D; Ulu A; Akar N
Clin Appl Thromb Hemost; 2009 Feb; 15(1):73-7. PubMed ID: 18160588
[TBL] [Abstract][Full Text] [Related]
18. Relative risk of pulmonary embolism and deep vein thrombosis in association with the factor V Leiden mutation in a United Kingdom population.
Baglin TP; Brown K; Williamson D; Baker P; Luddington R
Thromb Haemost; 1997 Jun; 77(6):1219. PubMed ID: 9241762
[No Abstract] [Full Text] [Related]
19. [C677T mutation in methylentetrahydrofolatereductase gene in patients with venous thromboses from the central region of Russia correlates with a high risk of pulmonary artery thromboembolism].
Avdonin PV; Kirienko AI; Kozhevnikova LM; Shostak NA; Babadaeva NM; Leont'ev SG; Petukhov EB; Kubatiev AA; Savel'ev VS
Ter Arkh; 2006; 78(6):70-6. PubMed ID: 16881367
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the risk of pulmonary embolism and deep vein thrombosis in the presence of factor V Leiden or prothrombin G20210A.
Ordóñez AJ; Carreira JM; Alvarez CR; Rodríguez JM; Alvarez MV; Coto E
Thromb Haemost; 2000 Feb; 83(2):352-4. PubMed ID: 10739402
[No Abstract] [Full Text] [Related]
[Next] [New Search]
